Slide 014

Next
Previous
Narrative
Beginning
End
Home page

Rifamycin SV is one of the rifamycin antibiotics isolated from Streptomyces mediterranei in 1957.  It is active only parenterally.  The orally active rifampicin was obtained through synthetic modification.  Rifampicin has a broad spectrum against bacteria but it is its activity against M. tuberculosis that is the most remarkable and important.

To top

www.tbrieder.org - Updated: 25-Apr-07